Great Information, Real Community, Better Living.
 Main Page
 Fibroids1 News
Feature Story
 Education Center

Find a Physician

Dr. Lauren Streicher  Fibroids

Dr. Lauren Streicher:
Educating Patients on their Options
About Heroes 
 Join the Discussion  in  Our Forums
Fibroids1 Forums
Patient Stories
One Question Poll


Online Resources
Patient Brochures
Locate a Specialist
Office Visits
    Asked Questions

Video Library

Search the Body1 Network
April 18, 2021  
FIBROIDS1 NEWS: Feature Story

  • Print this Article
  • Email this Article
  • Links/Reprints
  • FibroidEmbolization

    Long-Term Data Show Uterine Fibroid Embolization Is Effective

    June 26, 2010

    Source: Society of Interventional Radiology

    Data presented at the 30th Annual Scientific Meeting of the Society of Interventional Radiology found that the nonsurgical embolization treatment for uterine fibroids had a 73 percent success rate at five years. Uterine fibroid embolization (UFE) is a minimally invasive interventional radiology treatment that blocks the blood supply to the fibroid tumors, causing them to shrink and die, alleviating symptoms.

    Because it is minimally-invasive, has a much quicker recover time than open surgery, and preserves the uterus, this newer treatment has become increasing popular among
    Advantages of Uterine Fibroid Embolization

  • Doesn't require surgery

  • Much quicker recovery time

  • Preserves the uterus

  • Muscle protein synthesis isn't stimulated

  • women. Uterine fibroids are very common noncancerous (benign) growths that develop in the muscular wall of the uterus in up to 40 percent of women age 35 and older and the cause of approximately 200,000 hysterectomies in the United States annually. Most women with symptomatic fibroids are candidates for UFE.

    An estimated 13,000-14,000 UFE procedures are performed annually in the U.S. During a uterine fibroid embolization, the interventional radiologist makes a tiny nick in the skin and inserts a catheter into the femoral artery in the groin. Using real-time imaging, the physician guides the catheter through the artery and then releases tiny particles, the size of grains of sand, into the uterine arteries that supply blood to the fibroid tumor. This blocks the blood flow to the fibroid tumor and causes it to shrink and die. The embolic particles are approved by the FDA with as specific indication to treat uterine fibroid tumors.

    "Some gynecologists have been waiting for long-term data before being comfortable recommending the UFE procedure, and now that we have that data, I think patients will be hearing more about UFE as a nonsurgical option. The results are comparable to myomectomy, a procedure in which the fibroids are surgically removed, but UFE is less invasive, and women recover from it more quickly," says James B. Spies, M.D., Professor of Interventional Radiology at Georgetown University Medical Center and the study's principal investigator. "With any of the uterine-sparing treatments, growth of new fibroids is possible, and we saw this occurring in some patients during the later part of follow-up in this study. The same phenomenon is seen with myomectomy, with reintervention rates in the same range." Spies added, "The next step in fibroid research is to design direct comparative studies between the various therapies to provide data as to which patients are best suited for each treatment."

    In this study, 182 of 200 patients completed five-year follow-up with data available for analysis, and 18 were lost to follow-up. Outcomes were assessed by a questionnaire and patient symptom status, interval interventions, and menstrual cycle regularity. Treatment failure was defined as hysterectomy, myomectomy (surgical removal of the fibroids) or repeated embolization or failure of symptom control for two follow-up intervals. Using this measure, 20 percent of patients had either failed or recurred with new fibroids at 5 years after treatment. Among this group, there were 25 hysterectomies (4 were non-fibroid related), 6 myomectomies and 3 repeated embolizations. Seventy-three percent of patients had continued symptom control at the 5-year follow-up interval.

    UFE usually requires a hospital stay of one night. Many women resume light activities in a few days and the majority of women are able to return to normal activities within seven to 10 days.

    Discuss in the Fibroids1 forums

    Photo: Evo

    Last updated: 26-Jun-10


  • Add Comment
    Interact on Fibroids1

    Discuss this topic with others.
    Feature Archives

    Uterine Fibroids: If in Doubt Always Ask for a Second Opinion

    With Flip of Wrist, Interventional Radiologists Treat Uterine Fibroids

    Fibroids Have Significant Impact on Workplace Performance

    Uterine fibroids have greater impact in African American women

    Should Women with Fibroids have a Hysterectomy?

    Next 5 Features ...

    More Features ...
    Related Multimedia

    Interview with James Spies, M.D. - Treating and Evaluating Patients with Fibroids

    Interview with James Spies, M.D. - Fibroids: Who should be treated and who should not?

    Interview with James Spies, M.D. - Fibroids, Symptoms and Benefits of the Solution

    More Features ...
    Related Content
    Nonsurgical Treatment For Uterine Fibroids

    Vitamin D May Reduce Risk Of Uterine Fibroids

    Fibroids Have Significant Impact on Workplace Performance

    Genetic Risk Discovered For Uterine Fibroids

    Partial Embolization Effective for Uterine Fibroids

    More Features ...
    Home About Us Press Jobs Advertise With Us Contact Us
    © 2021 Body1 All rights reserved.
    Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.